Non-Opioid Pain Patches Market: Information by Patch Type (Lidocaine Patches, Diclofenac Patches), Distribution Channel (Hospitals, Online Pharmacies), and Region—Forecast Till 2027

Request Free Sample Report

Table Of Content

TABLE OF CONTENTS

1          Introduction

1.1       Market Definition

1.2       Market Scope

2          Research Methodology

2.1       Primary Research

2.2       Research Methodology

2.3       Assumptions & Exclusions

2.4       Secondary Data Sources

3          Market Overview

3.1       Report Segmentation & Scope

3.2       Value Chain Analysis: Global Non-opioid Pain Patches Market

3.3       Key Market Trends

3.3.1   Drivers

3.3.2   Restraints

3.3.3   Opportunities

3.4       Porter’s Five Forces Analysis

3.4.1   Bargaining Power of Suppliers

3.4.2   Bargaining Power of Buyers

3.4.3   Threat of Substitution

3.4.4   Threat of New Entrants

3.4.5   Competitive Rivalry

3.5       Market Share Analysis

4          Type Overview

4.1       Introduction

4.1.1   Market Size & Forecast (Value)

4.2       Lidocaine Patches

4.2.1   Market Size & Forecast (Value)

4.3       Diclofenac Patches      

4.3.1   Market Size & Forecast (Value)

4.4       Methyl Salicylate Patches

4.4.1   Market Size & Forecast (Value)

5          Distribution Channel Overview

5.1       Introduction

5.1.1   Market Size & Forecast (Value)

5.2       Hospital

5.2.1   Market Size & Forecast (Value)

5.3       Online Pharmacies

5.3.1   Market Size & Forecast (Value)

5.4       Drug Stores

5.4.1   Market Size & Forecast (Value)

6          Regional Overview

6.1      Introduction

6.1.1   Market Size & Forecast (Value)

6.2      America

6.2.1   North America

6.2.1.1 U.S.

6.2.1.1.1         By Type

6.2.1.1.2         By Distribution Channel

6.2.1.2 Canada

6.2.1.2.1         By Type

6.2.1.2.2         By Distribution Channel

6.2.1.3 Mexico

6.2.1.3.1         By Type

6.2.1.3.2         By Distribution Channel

6.2.2   Latin America

6.2.2.1      By Type

6.2.2.2      By Distribution Channel

6.2.2.2.1   Brazil

6.2.2.2.1.1      By Type

6.2.2.2.1.2      By Distribution Channel

6.2.2.2.2   Argentina

6.2.2.2.2.1      By Type

6.2.2.2.2.2      By Distribution Channel

6.2.2.2.3   Rest of South America

6.2.2.2.3.1      By Type

6.2.2.2.3.2      By Distribution Channel

6.3      Europe

6.3.1   Market Size & Forecast (Value)

6.3.2   Western Europe

6.3.2.1 U.K

6.3.2.1.1         By Type

6.3.2.1.2         By Distribution Channel

6.3.2.2 Germany

6.3.2.2.1         By Type

6.3.2.2.2         By Distribution Channel

6.3.2.3 France

6.3.2.3.1         By Type

6.3.2.3.2         By Distribution Channel

6.3.2.4 Spain

6.3.2.4.1         By Type

6.3.2.4.2         By Distribution Channel

6.3.2.5 Italy

6.3.2.5.1         By Type

6.3.2.5.2         By Distribution Channel

6.3.2.6 Rest of Western Europe

6.3.2.6.1         By Type

6.3.2.6.2         By Distribution Channel

6.3.3   Eastern Europe

6.3.3.1             By Type

6.3.3.2             By Distribution Channel

6.3.4   Rest of Europe

6.3.4.1             By Type

6.3.4.2             By Distribution Channel

6.4      Asia Pacific

6.4.1   Market Size & Forecast (Value)

6.4.2   Japan

6.4.2.1            By Type

6.4.2.2            By Distribution Channel

6.4.3   China

6.4.3.1            By Type

6.4.3.2            By Distribution Channel

6.4.4   Australia

6.4.4.1            By Type

6.4.4.2            By Distribution Channel

6.4.5   India

6.4.5.1            By Type

6.4.5.2            By Distribution Channel

6.4.6   South Korea

6.4.6.1            By Type

6.4.6.2            By Distribution Channel

6.4.7   Rest of Asia-Pacific

6.4.7.1            By Type

6.4.7.2            By Distribution Channel

6.5      Middle East & Africa

6.5.1   The Middle East

6.5.1.1            Market Size & Forecast (Value)

6.5.1.2            Saudi Arabia

6.5.1.2.1         By Type

6.5.1.2.2         By Distribution Channel

6.5.1.3 UAE

6.5.1.3.1         By Type

6.5.1.3.2         By Distribution Channel

6.5.1.4 Qatar

6.5.1.4.1         By Type

6.5.1.4.2         By Distribution Channel

6.5.2   The Africa

6.5.2.1            Market Size & Forecast (Value)

7          Company Profile

7.1      GlaxoSmithKline plc.

7.1.1   Company Overview

7.1.2   Financial Performance

7.1.3   Recent Developments

7.1.4   Type Portfolio

7.2      Acorda Therapeutics

7.2.1   Company Overview

7.2.2   Financial Performance

7.2.3   Recent Developments

7.2.4   Type Portfolio

7.3      Teva Pharmaceutical

7.3.1   Company Overview

7.3.2   Financial Performance

7.3.3   Recent Developments

7.3.4   Type Portfolio

7.4      IBSA Institute Biochimque.

7.4.1   Company Overview

7.4.2   Financial Performance

7.4.3   Recent Developments

7.4.4   Type Portfolio

7.5      Allergan

7.5.1    Company Overview

7.5.2   Financial Performance

7.5.3   Recent Developments

7.5.4   Type Portfolio

7.6      Teikoku Seiyaku Co. Ltd.

7.6.1   Company Overview

7.6.2   Financial Performance

7.6.3   Recent Developments

7.6.4   Type Portfolio

7.7      Teh Seng Pharmaceutical

               7.7.1 Company Overview

7.7.2   Financial Performance

7.7.3   Recent Developments

7.7.4   Type Portfolio

7.8      Hisamitsu Pharmaceutical.

7.8.1   Company Overview

7.8.2   Financial Performance

7.8.3   Recent Developments

7.8.4   Type Portfolio

7.9         Others

7.9.1   Company Overview

7.9.2   Financial Performance

7.9.3   Recent Developments

7.9.4   Type Portfolio

Report Description Download Sample

Copyright . All rights Reserved By Straits Research